Healthy Extracts (HYEX) Net Equity Issued and Repurchased (2015 - 2023)
Healthy Extracts (HYEX) posted quarterly Net Equity Issued and Repurchased of -$55000.0 for Q4 2023, down 57.14% quarter-over-quarter from -$35000.0 in Q3 2023.
Healthy Extracts (HYEX) Net Equity Issued and Repurchased (2015 - 2023) Analysis & Trends
Healthy Extracts' Net Equity Issued and Repurchased history runs 5 years deep, the most recent figure standing at -$55000.0 for Q4 2023.
- In Q4 2023, Net Equity Issued and Repurchased changed N/A year-over-year to -$55000.0; the TTM figure through Sep 2024 stood at -$55000.0 (down 57.14% YoY), while the FY2023 annual figure was -$90000.0, down 690.44% from the prior year.
- Net Equity Issued and Repurchased for Q4 2023 stood at -$55000.0, down from -$35000.0 in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $2.1 million in Q3 2020, with the low at -$1.7 million in Q4 2020.
- The 4-year median for Net Equity Issued and Repurchased is -$31708.5 (2022), against an average of $124517.6.
- The sharpest annual moves came in 2021 and 2023: Net Equity Issued and Repurchased jumped 144.39% in 2021, then tumbled 164.54% in 2023.
- Healthy Extracts' Net Equity Issued and Repurchased stood at -$1.7 million in 2020, then jumped by 144.39% to $770199.0 in 2021, then slumped by 92.96% to $54231.0 in 2022, then tumbled by 201.42% to -$55000.0 in 2023.
- Business Quant data shows HYEX's Net Equity Issued and Repurchased at -$55000.0 in Q4 2023, -$35000.0 in Q3 2023, and $54231.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Healthy Extracts | 19.90 Mn | 19.71 Mn | 1.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -55,000.00 |
| Dec 31, 2023 | -55,000.00 |
| Sep 30, 2023 | -35,000.00 |
| Sep 30, 2023 | -35,000.00 |
| Sep 30, 2022 | 54,231.00 |
| Sep 30, 2022 | 54,231.00 |
| Jun 30, 2022 | -37,200.00 |
| Jun 30, 2022 | -37,200.00 |
| Mar 31, 2022 | -28,417.00 |
| Mar 31, 2022 | -28,417.00 |
| Dec 31, 2021 | 770,199.00 |
| Dec 31, 2021 | 770,199.00 |
| Jun 30, 2021 | -281,880.00 |
| Jun 30, 2021 | -281,880.00 |
| Mar 31, 2021 | 506,880.00 |
| Mar 31, 2021 | 506,880.00 |
| Dec 31, 2020 | -1.74 Mn |
| Dec 31, 2020 | -1.74 Mn |
| Sep 30, 2020 | 2.09 Mn |
| Sep 30, 2020 | 2.09 Mn |